can
SAR
.ai
Menu
No data available
Cite
About us
Data Sources
Publications
cpat
csat
Browse
Publications
Published papers and additional files
canSAR chemistry registration and standardization pipeline
Daniela Dolciami, Eloy Villasclaras-Fernandez, Christos Kannas, Mirco Meniconi, Bissan Al-Lazikani & Albert A. Antolin
Journal of Cheminformatics volume 14, Article number: 28 (2022)
Abstract
Full text
PDF
canSAR: update to the cancer translational research and drug discovery knowledgebase
Costas Mitsopoulos, Patrizio Di Micco, Eloy Villasclaras Fernandez, Daniela Dolciami, Esty Holt, Ioan L. Mica, Elizabeth A. Coker, Joseph E. Tym, James Campbell, Ka Hing Che, Bugra Ozer, Christos Kannas, Albert A. Antolin, Paul Workman, Bissan Al-Lazikani
Nucl. Acids Res. 2021 Jan 8;49(D1):D1074-D1082. doi: 10.1093/nar/gkaa1059
Abstract
Full text
PDF
canSAR: update to the cancer translational research and drug discovery knowledgebase
Elizabeth A. Coker, Costas Mitsopoulos, Joesph E. Tym, Angeliki Komianou, Christos Kannas, Patrizio Di Micco, Eloy Villasclaras Fernandez, Bugra Ozer, Albert A. Antolin, Paul Workman, Bissan Al-Lazikani
Nucleic Acids Res. 2019 Jan 8;47(D1):D917-D922. doi: 10.1093/nar/gky1129. PMID: 30496479; PMCID: PMC6323893.
Abstract
Full text
PDF
The canSAR data hub for drug discovery
Cindy H Chau, Barry R O'Keefe, William D Figg
Lancet Oncol. 2016; 17(3):286. doi: 10.1016/S1470-2045(16)00095-4
Abstract
Full text
PDF
canSAR: an updated cancer research and drug discovery knowledgebase
Joseph E. Tym†, Costas Mitsopoulos†, Elizabeth A. Coker, Parisa Razaz, Amanda C. Schierz, Albert A. Antolin and Bissan Al-Lazikani
Nucl. Acids Res. (04 January 2016) 44 (D1): D938-D943. doi: 10.1093/nar/gkv1030
Abstract
Full text
PDF
Distinctive behaviors of druggable proteins in cellular networks
Costas Mitsopoulos, Amanda C. Schierz, Paul Workman, Bissan Al-Lazikani.
PLOS Computational Biology, 2015; 11 (12): e1004597 DOI: 10.1371/journal.pcbi.1004597
Abstract
Full text
PDF
canSAR: updated cancer research and drug discovery knowledgebase
Krishna C. Bulusu, Joseph E. Tym, Elizabeth A. Coker, Amanda C. Schierz, and Bissan Al-Lazikani.
Nucleic Acids Research 2014; doi: 10.1093/nar/gkt1182
Abstract
Full text
PDF
Drugging cancer genomes
Paul Workman & Bissan Al-Lazikani
Nat Rev Drug Discov. 2013 Dec; 12(12):889-90. doi:10.1038/nrd4184
Abstract
Full text
PDF
Objective Assessment of Cancer Genes for Drug Discovery
Mishal N. Patel, Mark D. Halling-Brown, Joseph E. Tym, Paul Workman and Bissan Al-Lazikani
Nat Rev Drug Discov. 2013 Jan; 12(1):35-50. doi: 10.1038/nrd3913
Abstract
Full text
PDF
Combinatorial drug therapy for cancer in the post-genomic era
Bissan Al-Lazikani, Udai Banerji & Paul Workman
Nat Biotechnol. 2012 Jul 10; 30(7):679-92. doi:10.1038/nbt.2284
Abstract
Full text
PDF
Personalized Medicine: Patient-Predictive Panel Power
Paul Workman, Paul A. Clarke, Bissan Al-Lazikani
Cancer Cell. 2012 Apr 17; 21(4):455-8. doi: 10.1016/j.ccr.2012.03.030
Abstract
Full text
PDF
canSAR: an integrated cancer public translational research and drug discovery resource
Mark D. Halling-Brown; Krishna C. Bulusu; Mishal Patel; Joe E. Tym; Bissan Al-Lazikani
Nucleic Acids Research 2011; doi: 10.1093/nar/gkr881
Abstract
Full text
PDF
